Alkem Laboratories Ipo


'Alkem Laboratories Ipo' - 14 News Result(s)

  • Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab

    Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab

    Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.

  • Dr Lal PathLabs, Alkem Lab Soar Over 30% on Debut

    Dr Lal PathLabs, Alkem Lab Soar Over 30% on Debut

    Generics drugmaker Alkem Laboratories shares jumped nearly 33 per cent to hit a high of Rs 1,401. The company had raised Rs 1,350 crore in its initial public offering after pricing shares at Rs 1,050 each. Alkem Laboratories' IPO was subscribed 44.3 times.

  • Alkem, Dr Lal IPOs Draw Overwhelming Response

    Alkem, Dr Lal IPOs Draw Overwhelming Response

    The IPO of Alkem Lab generated demand worth about Rs 59,000 crore, as it received bids for 40,18,87,794 shares against the total issue size of 90,87,084 shares, according to the data available with the NSE till 1900 hrs.

  • Alkem, Dr Lal PathLabs IPO Get Strong Response

    Alkem, Dr Lal PathLabs IPO Get Strong Response

    Dr. Lal Pathlabs' Rs 630 crore IPO, whose bookbuilding also ends on Thursday, was subscribed about 33 times the number of available shares.

  • Alkem Laboratories IPO Fully Subscribed

    Alkem Laboratories IPO Fully Subscribed

    Alkem had received orders for about 11.8 million shares, or about 1.3 times the number of shares being offered as of 3:48 p.m., according to data from exchanges National Stock Exchange and BSE Ltd.

  • Alkem Labs IPO: Should You Invest?

    Alkem Labs IPO: Should You Invest?

    Alkem Laboratories, India's fifth largest drugmaker with a 3.6 per cent market share, is selling 1.3 crore shares in the price band of Rs 1,020-Rs 1,050. The issue opened on Tuesday (December 8, 2015) and will close on Thursday (December 10). Investors can apply for a minimum of 14 shares.

  • Buy Persistent Systems, Relaxo Footwears: Siddharth Sedani

    Buy Persistent Systems, Relaxo Footwears: Siddharth Sedani

    Siddharth Sedani, AVP(advisory) at Sharekhan, believes that the current market fall is a great opportunity for investors to buy good quality stocks for next two years, because US Fed's move will not create an alarming situation globally in terms liquidity as other central banks are doing their best to keep the liquidity going.

  • Alkem May Announce IPO Price Band Soon: Report

    Alkem May Announce IPO Price Band Soon: Report

    Drugmaker Alkem Laboratories Ltd, which is raising about Rs 1,344 crore ($201.3 million) through an initial public offering, could announce the price band on November 30 or December 1, according to two sources familiar with the matter.

  • Two IPOs to Hit Stock Markets Next Week; Target to Mop Up Rs 2,000 Crore

    Two IPOs to Hit Stock Markets Next Week; Target to Mop Up Rs 2,000 Crore

    Aiming to tap the upbeat investor sentiments, two companies -- Alkem Laboratories and Dr Lal Pathlabs -- will hit the capital markets next week, to raise an estimated Rs 2,000 crore through IPOs.

  • Alkem Labs Eyes $210 Million IPO in December: Report

    Alkem Labs Eyes $210 Million IPO in December: Report

    Drug manufacturer Alkem Laboratories Ltd is set to launch an initial public offering (IPO) worth nearly $210 million (Rs 1,374 crore) in the second week of December, three sources directly involved in the transaction said on Tuesday.

  • Alkem Laboratories Gets Sebi's Nod to Float IPO

    Alkem Laboratories Gets Sebi's Nod to Float IPO

    Alkem Laboratories filed the Draft Red Herring Prospectus (DRHP) with Sebi on August 6 for a public issue of its equity shares.

  • Alkem Lab Approaches Sebi to Raise up to Rs 3,500 Cr via IPO

    Alkem Lab Approaches Sebi to Raise up to Rs 3,500 Cr via IPO

    Drug maker Alkem Laboratories on Thursday filed draft papers with market regulator Securities and Exchange Board of India (Sebi) to raise an estimated Rs 1,500-3,500 crore through initial public offering (IPO).

  • Alkem Laboratories to Raise Rs 1,500-3,500 Crore via IPO: Report

    Alkem Laboratories to Raise Rs 1,500-3,500 Crore via IPO: Report

    The move follows the blockbuster IPO of Syngene International, biotechnology major Biocon's research arm. With this public offer, the company is expected to be valued at around Rs 15,000 crore.

  • Alkem Labs Appoints Banks for Rs 1,800 Crore IPO: Report

    Alkem Labs Appoints Banks for Rs 1,800 Crore IPO: Report

    Drug manufacturer Alkem Laboratories has appointed Nomura and Axis Capital as lead bankers for a planned Rs 1500 crore to Rs 1800 crore initial public offering, five sources involved in the process told Reuters.

'Alkem Laboratories Ipo' - 14 News Result(s)

  • Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab

    Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab

    Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.

  • Dr Lal PathLabs, Alkem Lab Soar Over 30% on Debut

    Dr Lal PathLabs, Alkem Lab Soar Over 30% on Debut

    Generics drugmaker Alkem Laboratories shares jumped nearly 33 per cent to hit a high of Rs 1,401. The company had raised Rs 1,350 crore in its initial public offering after pricing shares at Rs 1,050 each. Alkem Laboratories' IPO was subscribed 44.3 times.

  • Alkem, Dr Lal IPOs Draw Overwhelming Response

    Alkem, Dr Lal IPOs Draw Overwhelming Response

    The IPO of Alkem Lab generated demand worth about Rs 59,000 crore, as it received bids for 40,18,87,794 shares against the total issue size of 90,87,084 shares, according to the data available with the NSE till 1900 hrs.

  • Alkem, Dr Lal PathLabs IPO Get Strong Response

    Alkem, Dr Lal PathLabs IPO Get Strong Response

    Dr. Lal Pathlabs' Rs 630 crore IPO, whose bookbuilding also ends on Thursday, was subscribed about 33 times the number of available shares.

  • Alkem Laboratories IPO Fully Subscribed

    Alkem Laboratories IPO Fully Subscribed

    Alkem had received orders for about 11.8 million shares, or about 1.3 times the number of shares being offered as of 3:48 p.m., according to data from exchanges National Stock Exchange and BSE Ltd.

  • Alkem Labs IPO: Should You Invest?

    Alkem Labs IPO: Should You Invest?

    Alkem Laboratories, India's fifth largest drugmaker with a 3.6 per cent market share, is selling 1.3 crore shares in the price band of Rs 1,020-Rs 1,050. The issue opened on Tuesday (December 8, 2015) and will close on Thursday (December 10). Investors can apply for a minimum of 14 shares.

  • Buy Persistent Systems, Relaxo Footwears: Siddharth Sedani

    Buy Persistent Systems, Relaxo Footwears: Siddharth Sedani

    Siddharth Sedani, AVP(advisory) at Sharekhan, believes that the current market fall is a great opportunity for investors to buy good quality stocks for next two years, because US Fed's move will not create an alarming situation globally in terms liquidity as other central banks are doing their best to keep the liquidity going.

  • Alkem May Announce IPO Price Band Soon: Report

    Alkem May Announce IPO Price Band Soon: Report

    Drugmaker Alkem Laboratories Ltd, which is raising about Rs 1,344 crore ($201.3 million) through an initial public offering, could announce the price band on November 30 or December 1, according to two sources familiar with the matter.

  • Two IPOs to Hit Stock Markets Next Week; Target to Mop Up Rs 2,000 Crore

    Two IPOs to Hit Stock Markets Next Week; Target to Mop Up Rs 2,000 Crore

    Aiming to tap the upbeat investor sentiments, two companies -- Alkem Laboratories and Dr Lal Pathlabs -- will hit the capital markets next week, to raise an estimated Rs 2,000 crore through IPOs.

  • Alkem Labs Eyes $210 Million IPO in December: Report

    Alkem Labs Eyes $210 Million IPO in December: Report

    Drug manufacturer Alkem Laboratories Ltd is set to launch an initial public offering (IPO) worth nearly $210 million (Rs 1,374 crore) in the second week of December, three sources directly involved in the transaction said on Tuesday.

  • Alkem Laboratories Gets Sebi's Nod to Float IPO

    Alkem Laboratories Gets Sebi's Nod to Float IPO

    Alkem Laboratories filed the Draft Red Herring Prospectus (DRHP) with Sebi on August 6 for a public issue of its equity shares.

  • Alkem Lab Approaches Sebi to Raise up to Rs 3,500 Cr via IPO

    Alkem Lab Approaches Sebi to Raise up to Rs 3,500 Cr via IPO

    Drug maker Alkem Laboratories on Thursday filed draft papers with market regulator Securities and Exchange Board of India (Sebi) to raise an estimated Rs 1,500-3,500 crore through initial public offering (IPO).

  • Alkem Laboratories to Raise Rs 1,500-3,500 Crore via IPO: Report

    Alkem Laboratories to Raise Rs 1,500-3,500 Crore via IPO: Report

    The move follows the blockbuster IPO of Syngene International, biotechnology major Biocon's research arm. With this public offer, the company is expected to be valued at around Rs 15,000 crore.

  • Alkem Labs Appoints Banks for Rs 1,800 Crore IPO: Report

    Alkem Labs Appoints Banks for Rs 1,800 Crore IPO: Report

    Drug manufacturer Alkem Laboratories has appointed Nomura and Axis Capital as lead bankers for a planned Rs 1500 crore to Rs 1800 crore initial public offering, five sources involved in the process told Reuters.

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com

................................ Advertisement ................................

................................ Advertisement ................................